Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma.
Leonard LD, Beaty L, Thomas M, Quinn C, Colborn KL, de Araujo TB, Torphy RJ, Assumpção LR, Olino K, Studts CR, Rodriguez Franco S, McCarter M, Stewart C, Gleisner AL.
Leonard LD, et al. Among authors: assumpcao lr.
J Surg Oncol. 2023 Mar;127(4):716-726. doi: 10.1002/jso.27153. Epub 2022 Dec 1.
J Surg Oncol. 2023.
PMID: 36453464